Motor neuron diseases (MNDs) are a group of progressive neurological disorders that affect the motor neurons in the brain and spinal cord. The motor neurons are responsible for controlling voluntary muscle movement such as speaking, walking, and breathing. Over time, MNDs can result in muscle weakness and paralysis. The causes of MNDs are not completely understood. Some forms of MNDs run in families, while others are caused by exposure to toxic substances or infections. Exposure to environmental factors like toxins or excess stress may increase with susceptibility to MNDs. Mylestated diseases, amyotrophic lateral sclerosis (ALS), progressive muscular atrophy (PMA), primary lateral sclerosis (PLS), progressive bulbar palsy (PBP), primary muscular atrophy (PMA) and inherited motor neuron syndromes such as hereditary motor neuron pathology (HMN) are some common types of MNDs. Symptoms of MNDs may vary from one individual to another depending on the specific disorder. In general, the most common symptom is muscle weakness and/or paralysis, which can begin in the limited area such as a single hand or foot and progress to other parts of the body. Additional symptoms can include muscle wasting, twitching, stiffness, difficulty in speaking and swallowing, and difficulty in breathing. Diagnosis of MNDs is done through a physical examination, imaging tests, blood and urine tests, and a number of nerve tests. Treatment options for MNDs vary depending on the disorder and severity of the symptoms. Medications may be used to slow down the progression of the disease, while physical therapy, occupational therapy, and supportive devices such as braces and wheelchairs can help maintain muscle function. In some cases, surgery and stem cell therapy may also be recommended. The prognosis for MNDs is typically worse than other types of neurological disorders because of the progressive nature of the disorder. However, with the use of early diagnosis and the right treatment, the progression of MNDs can be slowed down and the affected individuals can live longer and more comfortable lives.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States